HRT Financial’s Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares DNAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-80,224
Closed -$830K 3434
2023
Q2
$830K Buy
80,224
+5,358
+7% +$55.1K 0.01% 1060
2023
Q1
$766K Sell
74,866
-28
-0% -$284 0.01% 1089
2022
Q4
$754K Buy
74,894
+28
+0% +$278 0.01% 1158
2022
Q3
$733K Hold
74,866
0.01% 1201
2022
Q2
$727K Hold
74,866
0.01% 1225
2022
Q1
$729K Hold
74,866
0.01% 1350
2021
Q4
$740K Buy
74,866
+158
+0.2% +$1.56K ﹤0.01% 1441
2021
Q3
$738K Buy
74,708
+47,714
+177% +$470K ﹤0.01% 1642
2021
Q2
$273K Buy
+26,994
New +$273K ﹤0.01% 2205

HRT Financial's DNAB Position: Q3 2023 in Review

HRT Financial sold out of Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares (DNAB) in Q3 2023, closing a stake of 80,224 shares — an estimated $830K sold.

HRT Financial first reported a position in DNAB in Q2 2021 and held it in 9 quarters. The position peaked at $830K in Q2 2023. 0 funds tracked by Wall St. Rank hold DNAB as of Q3 2023.

  • HRT Financial reported no remaining Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 80,224 Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares shares in Q3 2023, an estimated $830K.
  • HRT Financial first reported a position in Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares in Q2 2021 and held it in 9 quarters.
  • HRT Financial's Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares position peaked at $830K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.